Therapy of Lymphoma/Leukemia with Monoclonal Antibodies

Peng Huang

ROS, Redox Regulation and Novel Targets for Cancer Therapy

Leukaemia

Alejandro Gutierrez

Discovery and targeting of apoptosis resistance mechanisms in high-risk T-ALL

Leukaemia

Paul Anthony Wender

Synthetic Studies Related to Cancer Research/Treatment

Hodgkin lymphoma Non-Hodgkin lymphoma

Corey Casper

Uganda Cancer Institute / Hutchinson Center Cancer Alliance (UCI/HCCA)

Hodgkin lymphoma Non-Hodgkin lymphoma

Brenda Marie Sandmaier

Alpha Radioimmunotherapy for Lymphoma Treatment

Non-Hodgkin lymphoma Hodgkin lymphoma

Nathanael S Gray

MALT1 inhibitors for the treatment of chemo-resistant ABC-DLBCL

Non-Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Suzanne McGoldrick

Burkitt Lymphoma Clinical Care Project

Non-Hodgkin lymphoma

Pediatric oncology or childhood cancer Hematology and hematologic malignancies Pathology

Talya Salz

Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?

Non-Hodgkin lymphoma Hodgkin lymphoma

Theodore S Jardetzky

Inhibitors of the Epstein-Barr Virus Entry Machinery

Hodgkin lymphoma Non-Hodgkin lymphoma